REFERENCES
1. Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16:217-21.
2. Du X, Guo L, Xia S, et al. Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China. Heart. 2021;107:535-41.
3. Chen Q, Xiong X, Li L, Gui C. Efficacy and safety of different forms of ablation therapies and antiarrhythmic drugs in atrial fibrillation: a systematic review and network meta-analysis of randomized clinical trials. J Thorac Dis. 2025;17:1323-34.
4. Sánchez-de-la-Torre M, Lee CH, Barbé F. Obstructive sleep apnea and atrial fibrillation: we need to go step by step. J Clin Sleep Med. 2021;17:869-70.
5. Linz D, Linz B, Hohl M, Böhm M. Atrial arrhythmogenesis in obstructive sleep apnea: therapeutic implications. Sleep Med Rev. 2016;26:87-94.
6. Goudis CA, Ketikoglou DG. Obstructive sleep and atrial fibrillation: Pathophysiological mechanisms and therapeutic implications. Int J Cardiol. 2017;230:293-300.
7. Szymanski FM, Filipiak KJ, Platek AE, et al. Presence and severity of obstructive sleep apnea and remote outcomes of atrial fibrillation ablations - a long-term prospective, cross-sectional cohort study. Sleep Breath. 2015;19:849-56.
8. Chilukuri K, Dalal D, Marine JE, et al. Predictive value of obstructive sleep apnoea assessed by the Berlin Questionnaire for outcomes after the catheter ablation of atrial fibrillation. Europace. 2009;11:896-901.
9. Zhai WX, Zhang TJ, Jia YH, et al. Effect of sleep apnea hypopnea syndro me on the prognosis of atrial fibrillation after radiofrequency catheter ablation. Chinese Circ J. 2022;37:1144-9. (in Chinese).
10. Lee CJ, Kim TH, Park S, Pak HN. Obstructive sleep apnea is closely related to cardiovascular risk factors, but not to clinical recurrence of atrial fibrillation after catheter ablation: an analysis of atrial fibrillation patients. Pulse. 2018;6:103-11.
11. Tang RB, Dong JZ, Liu XP, et al. Obstructive sleep apnoea risk profile and the risk of recurrence of atrial fibrillation after catheter ablation. Europace. 2009;11:100-5.
12. Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149:e1-156.
13. Chang JL, Goldberg AN, Alt JA, et al. International consensus statement on obstructive sleep apnea. Int Forum Allergy Rhinol. 2023;13:1061-482.
14. Desteghe L, Hendriks JML, Heidbuchel H, Potpara TS, Lee GA, Linz D. Obstructive sleep apnoea testing and management in atrial fibrillation patients: a joint survey by the European Heart Rhythm Association (EHRA) and the Association of Cardiovascular Nurses and Allied Professions (ACNAP). Europace. 2021;23:1677-84.
15. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999;131:485-91.
16. Desteghe L, Hendriks JML, McEvoy RD, et al. The why, when and how to test for obstructive sleep apnea in patients with atrial fibrillation. Clin Res Cardiol. 2018;107:617-31.
17. Kadhim K, Middeldorp ME, Elliott AD, et al. Self-reported daytime sleepiness and sleep-disordered breathing in patients with atrial fibrillation: SNOozE-AF. Can J Cardiol. 2019;35:1457-64.
18. de Heide J, Kock-Cordeiro DBM, Bhagwandien RE, et al. Impact of undiagnosed obstructive sleep apnea on atrial fibrillation recurrence following catheter ablation (OSA-AF study). Int J Cardiol Heart Vasc. 2022;40:101014.
19. Matiello M, Nadal M, Tamborero D, et al. Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients. Europace. 2010;12:1084-9.
20. Zheng N, Fu Y, Xue F, Xu M, Ling L, Jiang T. Which ablation strategy is the most effective for treating persistent atrial fibrillation? A systematic review and Bayesian network meta-analysis of randomized controlled trials. Heart Rhythm. 2025;22:e60-73.
21. Pranata R, Henrina J, Yonas E, et al. BMI and atrial fibrillation recurrence post catheter ablation: a dose-response meta-analysis. Eur J Clin Investig. 2021;51:e13499.
22. Nalliah CJ, Wong GR, Lee G, et al. Sleep apnoea has a dose-dependent effect on atrial remodelling in paroxysmal but not persistent atrial fibrillation: a high-density mapping study. Europace. 2021;23:691-700.
23. Ghias M, Scherlag BJ, Lu Z, et al. The role of ganglionated plexi in apnea-related atrial fibrillation. J Am Coll Cardiol. 2009;54:2075-83.
24. Choi EK, Zhao Y, Everett TH 4th, Chen PS. Ganglionated plexi as neuromodulation targets for atrial fibrillation. J Cardiovasc Electrophysiol. 2017;28:1485-91.
25. Yu L, Scherlag BJ, Sha Y, et al. Interactions between atrial electrical remodeling and autonomic remodeling: how to break the vicious cycle. Heart Rhythm. 2012;9:804-9.
26. Schlögl S, Schlögl KS, Bengel P, et al. Contact force sensing manual catheter versus remote magnetic navigation ablation of atrial fibrillation: a single-center comparison. Heart Vessels. 2024;39:427-37.
27. Alhuarrat MAD, Flomenbaum D, Schiavone M, et al. Ablation index-guided radiofrequency ablation for atrial fibrillation: an updated meta-analysis on its procedural efficacy and safety profiles. J Cardiovasc Electrophysiol. 2025;36:2597-607.
28. Kaddoura R, Abushanab D, Asaad N. Pulsed-field ablation versus radiofrequency or cryoballoon thermal ablation in atrial fibrillation: a systematic review and meta-analysis. Postgrad Med J. 2025;101:690-703.
29. De Becker B, El Haddad M, De Smet M, et al. Early atrial fibrillation recurrence post catheter ablation: Analysis from insertable cardiac monitor in the era of optimized radiofrequency ablation. Heart Rhythm. 2024;21:521-9.
30. Kim YG, Boo KY, Choi JI, et al. Early recurrence is reliable predictor of late recurrence after radiofrequency catheter ablation of atrial fibrillation. JACC Clin Electrophysiol. 2021;7:343-51.
31. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92:1954-68.
32. Gottlieb LA, Dekker LRC, Coronel R. The blinding period following ablation therapy for atrial fibrillation: proarrhythmic and antiarrhythmic pathophysiological mechanisms. JACC Clin Electrophysiol. 2021;7:416-30.
33. Carballo D, Noble S, Carballo S, et al. Biomarkers and arrhythmia recurrence following radiofrequency ablation of atrial fibrillation. J Int Med Res. 2018;46:5183-94.
34. Korodi S, Toganel R, Benedek T, et al. Impact of inflammation-mediated myocardial fibrosis on the risk of recurrence after successful ablation of atrial fibrillation - the FIBRO-RISK study: protocol for a non-randomized clinical trial. Medicine. 2019;98:e14504.
35. Hu YF, Chen YJ, Lin YJ, Chen SA. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;12:230-43.
